Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GW273225 Add-on Treatment for Partial Seizures
NCT00567424Phase 2Withdrawn
- Sponsor
- GSK
- Start
- Jul 2006
- Primary completion
- Mar 2008
- Countries
- 1
01
Overview
A Phase 2 trial of GW273225 in Focal Epilepsy (FE), sponsored by GSK. Planned start Jul 2006; status: withdrawn.
02
Drugs
GW273225
03
Conditions
Focal Epilepsy (FE)
Beyond the preview
Go deeper on NCT00567424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00567424.